NGEN NASDAQ
NervGen Pharma Corp. Common stock
1W: -3.9%
1M: -21.3%
3M: -6.9%
YTD: -74.8%
$1.48
+0.06 (+4.23%)
Weekly Expected Move ±6.4%
$1
$1
$1
$2
$2
Credit Risk of going bust: not rated Debt: 0.0% of company value Bonds: none of note held by US funds details ▾
Not rated: no debt. Altman Z'' -5.72.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Oct Typical
☁️
Cloudy
+0.0% YTD avg
2026 Now
☁️
Cloudy
Tracking typical
20yr Avg YTD
—
2026 YTD
—
Typical Vol
49%
Annualized
Monthly Weather Forecast
Jan
20yr
⛈️
-28.4%
0% win
60% vol
Feb
20yr
⛈️
-2.2%
0% win
57% vol
Mar
20yr
⛈️
-3.8%
0% win
66% vol
Apr
20yr
⛈️
-3.7%
0% win
77% vol
May
20yr
⛈️
-43.0%
0% win
160% vol
Jun
20yr
🌫️
-0.5%
0% win
81% vol
Jul
20yr
⛈️
-21.4%
0% win
53% vol
Aug
20yr
💨
+36.4%
100% win
48% vol
Sep
20yr
⛈️
-13.6%
0% win
62% vol
Oct
20yr
⛈️
-22.5%
0% win
49% vol
Now:
-22.5%
Dec
20yr
💨
+9.8%
100% win
110% vol